Sign up to save your podcasts
Or
Share ACC CardiaCast: Emerging Data in SGLT2 Inhibitors
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ACC CardiaCast: Emerging Data in SGLT2 Inhibitors
This podcast discusses new data pertaining to the class of SGLT2 inhibitors in the treatment of diabetes and its cardioprotective properties. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the results of the EMPA-REG OUTCOME (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients) trial will help prepare you to better treat your patients.
View all episodes
By American College of Cardiology
4.4
3737 ratings
This podcast discusses new data pertaining to the class of SGLT2 inhibitors in the treatment of diabetes and its cardioprotective properties. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the results of the EMPA-REG OUTCOME (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients) trial will help prepare you to better treat your patients.
More shows like ACC CardiaCast
View all
NEJM This Week
323 Listeners
JAMA Clinical Reviews
500 Listeners
JACC This Week
166 Listeners
Heart Podcast
40 Listeners
This Week in Cardiology
902 Listeners
JACC Specialty Journals
20 Listeners
Talking Points
3 Listeners
The Curbsiders Internal Medicine Podcast
3,375 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
137 Listeners
Core IM | Internal Medicine Podcast
1,151 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
62 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
ESC Cardio Talk
16 Listeners
Cardionerds: A Cardiology Podcast
433 Listeners
Mayo Clinic Cardiovascular CME
36 Listeners